Apimeds Pharmaceuticals US, Inc (APUS) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Drug Manufacturers - Specialty & Generic उद्योग. कंपनी का मुख्यालय है Hopewell, NJ, United States. वर्तमान CEO हैं Youngjik Cho.
APUS के पास है IPO तिथि 2025-05-09, 2 पूर्णकालिक कर्मचारी, पर सूचीबद्ध American Stock Excha, बाजार पूंजीकरण $2.36M.
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.
